Study Determines Association of Gallbladder Polyps and Gallbladder Cancer
Gallbladder cancer rates were found to be low and similar among both patients with and without gallbladder polyps, according to a recent study. (Source: CancerNetwork)
Source: CancerNetwork - May 26, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Stephen Schuster, MD, on Prioritizing Patients with Aggressive Lymphomas During COVID-19 Pandemic
Stephen Schuster, MD, discussed how they are prioritizing patients with more aggressive lymphomas, with emphasis on tumor volume and serum LDH levels during the COVID-19 pandemic. (Source: CancerNetwork)
Source: CancerNetwork - May 25, 2020 Category: Cancer & Oncology Authors: Stephen Schuster, MD Source Type: news
Increases in Melanoma Risk in Patients Treated with Biologic Therapy Not Ruled Out
Clinically important increases in melanoma risk in patients treated with biologic therapy for common inflammatory diseases cannot yet be ruled out based on current evidence. (Source: CancerNetwork)
Source: CancerNetwork - May 25, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Data Reveals DNA Variations that Alter Breast Cancer Risk in Women
A recent study found 32 new sites on the human genome where variations in a woman ’s DNA could alter her risk level, both increase and decrease, of getting breast cancer. (Source: CancerNetwork)
Source: CancerNetwork - May 24, 2020 Category: Cancer & Oncology Authors: Matthew Fowler Source Type: news
Optimizing Treatment for Patients with Metastatic Pancreatic Cancer, DNA Repair Defects
Researchers found that patients with metastatic pancreatic cancer who had germline or somatic mutations in DNA repair genes had better clinical outcomes after platinum-based chemotherapy. (Source: CancerNetwork)
Source: CancerNetwork - May 24, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Immune Checkpoint Inhibitors May Be Associated with High Activity in MSI-H Cancers
Patients with pretreated microsatellite instability-high cancers treated with immune checkpoint inhibitors were found to have high activity, independent of tumor type and drug used. (Source: CancerNetwork)
Source: CancerNetwork - May 23, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Medicaid Expansion May Have Survival Benefits for Men with NSCLC
This study suggested that Medicaid expansion could have survival benefits for men with non-small cell lung cancer, however the same association pattern was not observed for women. (Source: CancerNetwork)
Source: CancerNetwork - May 23, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Low-Dose Erlotinib Shows Promise in Elderly, Frail Patients with EGFR+ NSCLC
A phase II study indicated that low-dose erlotinib (Tarceva) appears to be safe and effective in elderly or frail patients with EGFR mutation-positive non-small cell lung cancer. (Source: CancerNetwork)
Source: CancerNetwork - May 22, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Review of the Clinical Utility of Predictive Computational Methods in Oncology
A workshop group assessed the use of multidimensional data obtained from patients with cancer and the computational methods used to analyze the data. (Source: CancerNetwork)
Source: CancerNetwork - May 22, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
FDA Approves Brigatinib to Treat Frontline ALK-Positive NSCLC
The FDA has approved brigatinib for the first-line treatment of patients with ALK-positive metastatic non –small cell lung cancer, as detected by an FDA-approved test. (Source: CancerNetwork)
Source: CancerNetwork - May 22, 2020 Category: Cancer & Oncology Authors: Kristie L. Kahl Source Type: news
Low Global Molecular Testing for Lung Cancer Calls for More Education
Given these findings, researchers indicated that continuous education around molecular testing in lung cancer should be intensified on both national and international levels to ensure patients receive optimal therapy. (Source: CancerNetwork)
Source: CancerNetwork - May 22, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Recommendations for Immune-Engaging Therapies During the COVID-19 Pandemic
Recommendations for patients who develop COVID-19 while receiving immunotherapy or other advanced immune-engaging therapies. (Source: CancerNetwork)
Source: CancerNetwork - May 22, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Simple Modifications of Phase I Trial Designs Could Reduce Time Required for New Advances
A recent study found that phase I queue designs were associated with a reduction in the expected study duration without changing risk limits or maximum tolerated dose determination when compared to the original parent design. (Source: CancerNetwork)
Source: CancerNetwork - May 21, 2020 Category: Cancer & Oncology Authors: Matthew Fowler Source Type: news
ASTRO Survey Reports Continued Radiation Therapy Services During Pandemic
The American Society for Radiation Oncology recently conducted an online survey of 222 US based, practicing radiation oncologists, finding that 100% continued to provide radiation therapy services during the COVID-19 pandemic. (Source: CancerNetwork)
Source: CancerNetwork - May 21, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Regional- and Distant-Stage Prostate Cancer Incidence Continues to Increase
This study found that regional- and distant-stage prostate cancer incidence continues to increase in US men aged ≥50 years. (Source: CancerNetwork)
Source: CancerNetwork - May 21, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
